Abstract:Background: Stent thrombosis, a life-threatening complication of percutaneous coronary intervention (PCI) continues to occur despite effective antiplatelet regimens and improved stenting methods. Noncompliance with dual antiplatelet therapy is the most common etiology; however, in spite of timely and their optimum administration the rates of recurrent myocardial infarction (MI) and stent thrombosis remain high. Clopidogrel resistance is increasingly evoked with elevated risk of anterothrombotic events particularly in the setting of stent implantation. In this case report, we present a case of subacute stent thrombosis associated with clopidogrel resistance in a resource-constrained setting. Case presentation: A 60 year old man with a long standing history of hypertension presented with a 6-month history of progressive shortness of breath. Initial electrocardiogram (ECG) revealed T-wave inversion on lateral leads and echocardiogram revealed akinetic basal lateral wall and hypokinetic mid lateral wall with reduced systolic functions. An elective coronary angiography (CAG) revealed a 90% stenosis of mid left anterior descending (LAD) artery and an 80% stenosis on the proximal left circumflex artery. He underwent a successful PCI with a drug-eluting stent implantation to mid LAD. He was discharged in a stable state 48 h post revascularization with dual antiplatelet (clopidogrel and acetylsalicylic acid). Seven days later, he presented with a crushing substernal chest pain. Cardiac enzymes were elevated and ECG revealed anterior ST-elevation MI. An emergency CAG revealed a high thrombus burden with 100% occlusion of mid LAD. Following unsuccessful ballooning, intravenous and intracoronary thrombolysis with tenecteplase was given. A TIMI II flow was achieved and the patient was sent to the coronary care unit. However, 14 h later there was yet a new onset of severe chest pain. A 12-lead ECG previewed anterior ST-elevation MI and the cardiac enzymes were high. Urgent CAG revealed in-stent thrombotic total occlusion of mid LAD. A stent in stent was then implanted and TIMI III flow was restored. Clopidogrel resistance was suspected and the patient was transitioned to ticagrelol. There were no further ischemic events during the remainder of hospitalization and the patient was discharged in a hemodynamically stable state three days later. During follow-up after one and three months, he was fairly stable without any further cardiac events. Conclusions: Owing to clopidogrel resistance, stent thrombosis in the setting of dual antiplatelet therapy compliance may occur. While in a situation of clopidogrel resistance newer and more potent antiplatelet drugs should be used, their availability and cost remains a significant barrier particularly in the developing world. Nonetheless, a high index of suspicion and timely revascularization is fundamental to restore patency of the thrombosed vessel and confer better risk-adjusted survival rates.

Late Stent Thrombosis after Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis.

Very Late Thrombosis in a Patient with a Drug-Eluting Stent for Intracranial Atherosclerotic Stenosis

Intrastent Haematoma After Treatment With A Drug-Eluting Balloon For In-Stent Restenosis: A Case Report

Coronary in-stent thrombosis caused by low reactivity to clopidogrel

A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis

Very Late Drug-Eluting Stent Thrombosis in the Perioperative Period of Endoscopic Choledocholithotomy.

Intracoronary thrombolysis combined with drug balloon angioplasty in a young ST-segment elevation myocardial infarction patient: A case report

Very Late Stent Thrombosis in Drug-Eluting Stents New Observations and Clinical Implications.

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases

Subacute saphenous vein graft stent thrombosis due to unusual drug interaction: a case report

Acute Stent Thrombosis after Stent-Assisted Coiling in an Intracranial Aneurysm Patient Carrying Two Reduced-Function CYP2C19 Alleles

Late Angiographic Stent Thrombosis in a Drug-Eluting Stent That Occurred 20 Months after Premature Discontinuation of Clopidogrel Administration.

Clinical Efficacy and Safety of Drug Coated Balloon for Treating In-Stent Restenosis of Left Anterior Descend?ing Complex Artery Lesion in Coronary

[Clinical Characteristics and Management of Patients with Acute or Subacute Coronary In-Stent Thrombosis].

Drug-Eluting Stent and Late Stent Thrombosis

[A Clinical Trial of Using Antiplatelet Therapy to Prevent Restenosis Following Peripheral Artery Angioplasty and Stenting].

Advancements in Prevention of Late Stent Thrombosis

Incidence and Predictors of Definite Stent Thrombosis after Coronary Stent Implantation.

An elderly case with late carotid stent thrombosis: possible role of antiphospholipid antibodies

A randomized trial of cilostazol versus ticlopidine for anti-platelet therapy after coronary artery stenting for prevention of restenosis

RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome.